Express Scripts Begins Investing In Part D
This article was originally published in The Pink Sheet Daily
Express Scripts is starting to incur expenses in anticipation of the Medicare drug benefit that begins in January 2006
You may also be interested in...
CEO Paz says employers are increasingly interested in alternative solutions to lower drug costs, such as mandatory generics and mandatory mail-order programs. While not the only consideration in choosing a drug plan, price will remain important to clients, the exec says.
DURHAM, N.C. - The decline in FDA's tally of new molecular entity approvals stems from fewer approvals of non-innovative products in recent years, while approvals of truly innovative products has largely held steady, according to FDA Deputy Commissioner for Policy, Planning and Preparedness Randall Lutter